Tag

Science Policy

All articles tagged with #science policy

Europe’s blueprint to become a bioengineering powerhouse: three bold changes
science-policy19 days ago

Europe’s blueprint to become a bioengineering powerhouse: three bold changes

A Nature commentary argues Europe is losing ground in bioengineering to the US and China and calls for a European bioengineering agenda built on three pillars: (1) build academic excellence with dedicated bioengineering departments and cutting‑edge curricula; (2) invest in bioengineers via new, dedicated funding schemes and independent review panels; and (3) establish industry engagement, tax incentives, and streamlined regulatory pathways to translate research into market and clinical use, supported by upcoming EU funding programs to create homegrown hubs and attract global talent.

Fix the incentives to curb AI-driven fraud in scientific publishing
science-policy26 days ago

Fix the incentives to curb AI-driven fraud in scientific publishing

Generative AI accelerates the publish-or-perish pressure by enabling rapid fabrication of papers, with detectors often lagging behind increasingly convincing AI-made content. While disclosure norms and screening tools help, experts say the core fix is systemic: reward quality over quantity, adopt data attestations and provenance standards, and align funders, institutions, and publishers to slow AI-enabled fraud. Detection buys time, but meaningful reform requires changing the incentives that drive researchers to publish large volumes.

UK physics labs at a funding cliff: monetize research or face closure
science-policy29 days ago

UK physics labs at a funding cliff: monetize research or face closure

UK physics facilities funded by STFC face a £42 million a year funding gap and risk closure unless they increasingly raise external income. A £135 million three‑year top‑up buys time to cut costs and grow commercial activity—such as paid beam time, technology licensing, and lab access—while beam time and jobs are set to shrink. The situation mirrors broader UK science funding reforms and lags behind some European labs in commercial income, leaving the sector at a crossroads about long‑term viability and the pace of change by 2030.

White House's 'New Golden Age' for science sparks debate over funding and coherence
technology1 month ago

White House's 'New Golden Age' for science sparks debate over funding and coherence

Ars Technica analyzes the White House OSTP report Science: A New Golden Age, which argues for streamlined grants, looser peer review, and closer ties between science and industry to accelerate science and AI innovation, but critics say the proposal is incoherent, ignores prior funding cuts, overstates its premises, and offers few clear mechanisms to move basic research into commercial advances.

Translational foresight: planning science for multiple futures
science-policy1 month ago

Translational foresight: planning science for multiple futures

The article argues that research programs should embed futures-thinking from the outset to avoid misalignment with future conditions. It promotes translational foresight—applying futures studies methods (like horizon scanning, the Futures Wheel, 2×2 scenario analysis, and backcasting Vision Writing) to funding, staffing, and infrastructure decisions. By explicitly uncovering and testing assumptions about technology maturation, public trust, and regulatory trajectories, and by planning trigger points for change, science can be better prepared for crises (e.g., COVID-19, AI advances) and for alternative futures. The piece calls for making these foresight practices routine in science policy and funding decisions to reduce reactive, crisis-driven shifts and improve long-term research outcomes.

White House Plan Shifts Federal Grants From Merit to Policy Alignment, Sparking Scientist Backlash
policy1 month ago

White House Plan Shifts Federal Grants From Merit to Policy Alignment, Sparking Scientist Backlash

The White House Office of Management and Budget proposed a sweeping rule to overhaul federal grantmaking by letting political appointees override merit reviews and require funding decisions to demonstrably advance the President’s priorities, with a 45-day public comment period ending July 13; critics warn the change could undermine scientific independence, limit international collaboration, and create instability for local infrastructure projects that rely on federal funding.

The AI-Driven Leap: Mass-Produced Science and the Scientist's New Role
technology1 month ago

The AI-Driven Leap: Mass-Produced Science and the Scientist's New Role

AI could mass-produce high-quality science—new analyses, data, figures, and conclusions—at low cost, benefiting the public and patients, but it will also create challenges in separating quality work from low-quality output. Reliability will hinge on new practices like open data, preregistration, and robust validation. Humans will still guide which questions to pursue, refine concepts, design and interpret experiments, and curate trustworthy results. The shift may resemble the Industrial Revolution: some jobs vanish while new roles emerge, with AI-enabled data integration and personalized review accelerating discoveries while reshaping careers in science.

Acknowledge bias: scientists urged to own politics to boost public trust
science-policy1 month ago

Acknowledge bias: scientists urged to own politics to boost public trust

UK data show trust in science remains relatively high but fragile and uneven across ideological groups; perceived bias—often linked to COVID-19—can erode confidence. The author argues scientists should recognise their own political biases and follow six public‑facing practices to put people at the heart of science and policy, thereby sustaining trust in science.

Trust in Science Isn’t Crumbling—Time to Fix the Gaps
science-policy1 month ago

Trust in Science Isn’t Crumbling—Time to Fix the Gaps

The piece argues that trust in science is not collapsing globally; surveys show middling to high trust, but confidence varies by country and group, with political polarization, perceived elitism, and rising vaccine hesitancy. It urges nuanced measures of trust, transparent communication about uncertainties, and greater public involvement in research priorities to address concerns and strengthen science’s link to society.

Public in the Lead: Six Paths to Democratic Science Policy
policy1 month ago

Public in the Lead: Six Paths to Democratic Science Policy

Nature argues that trust in elites is waning and public input should be embedded in research and policymaking through six steps: involve the public in research, make science advisory bodies participatory, embrace diverse knowledge (including Indigenous and community expertise), be humble and transparent about methods and uncertainties, acknowledge scientists’ values, and enable co-design with communities—citing EU Horizon 2020 priority setting, citizen panels influencing Danish and NASA decisions, and community-led mangrove restoration as evidence that public involvement boosts legitimacy and policy relevance.

Genesis Mission Takes Center Stage in US AI and Quantum Push
science-policy1 month ago

Genesis Mission Takes Center Stage in US AI and Quantum Push

Darío Gil, the DoE’s science under-secretary, is leading a high-profile push into AI and quantum science through the Genesis initiative, which aims to create an overarching AI platform that connects scientific instruments, supercomputers, and data across 17 national labs. The first Genesis funding round drew about 5,000 proposals and $293 million in awards, with the program totaling roughly $520 million so far. The effort coincides with a 2028 target to build a fault-tolerant quantum computer, even as researchers worry that basic-science funding could be squeezed by AI investments. Gil argues the funds will remain spread across disciplines and emphasizes collaboration with industry and academia to harness, safeguard, and guide AI’s future.

A Sickle Cell Breakthrough and the Peril of Political Attacks on Science
science1 month ago

A Sickle Cell Breakthrough and the Peril of Political Attacks on Science

A Louisiana man, Daniel Cressy, was functionally cured of sickle cell disease thanks to a breakthrough rooted in federally funded research, underscoring how modern medicine can dramatically improve lives—but the piece warns that Donald Trump’s anti-science stance could threaten such progress, which evolved from bone marrow transplants to newer therapies in the early 2010s.